Skip to main content

Table 2 Primers used for virulence factors used in this study

From: Differences of virulence factors, and antimicrobial susceptibility according to phylogenetic group in uropathogenic Escherichia coli strains isolated from Korean patients

Marker

Primer direction

Primer sequence (5′-3′)

Product length (bp)

papA

Forward

Reverse

ATGGCAGTGGTGTCTTTTGGTG

CGTCCCACCATACGTGCTCTTC

720

papC

Forward

Reverse

GTGGCAGTATGAGTAATGACCGTTA

ATATCCTTTCTGCAGGGATGCAATA

200

papEF

Forward

Reverse

GCAACAGCAACGCTGGTTGCATCAT

AGAGAGAGCCACTCTTATACGGACA

336

papG allele I

Forward

Reverse

TCGTGCTCAGGTCCGGAATTT

TGGCATCCCCCAACATTATCG

461

papG allele II

Forward

Reverse

GGGATGAGCGGGCCTTTGAT

CGGGCCCCCAAGTAACTCG

190

papG allele III

Forward

Reverse

GGCCTGCAATGGATTTACCTGG

CCACCAAATGACCATGCCAGAC

258

sfa/focDE

Forward

Reverse

CTCCGGAGAACTGGGTGCATFTTAC

CGGAGGAGTAATTACAAACCTGGCA

410

sfaS

Forward

Reverse

GTGGATACGACGATTACTGTG

CCGCCAGCATTCCCTGTATTC

240

focG

Forward

Reverse

CAGCACAGGCAGTGGATACGA

GAATGTCGCCTGCCCATTGCT

360

afa/draBC

Forward

Reverse

GGCAGAGGGCCGGCAACAGGC

CCCGTAACGCGCCAGCATCTC

559

bmaE

Forward

Reverse

ATGGCGCTAACTTGCCATGCTG

AGGGGGACATATAGCCCCCTTC

507

gafD

Forward

Reverse

TGTTGGACCGTCTCAGGGCTC

CTCCCGGAACTCGCTGTTACT

952

nfaE

Forward

Reverse

GCTTACTGATTCTGGGATGGA

CGGTGGCCGAGTCATATGCCA

559

fimH

Forward

Reverse

TGCAGAACGGATAAGCCGTGG

GCAGTCACCTGCCCTCCGGTA

508

hlyA

Forward

Reverse

AACAAGGATAAGCACTGTTCTGGCT

ACCATATAAGCGGTCATTCCCGTCA

1177

cnf1

Forward

Reverse

AAGATGGAGTTTCCTATGCAGGAG

CATTCAGAGTCCTGCCCTCATTATT

498

fyuA

Forward

Reverse

TGATTAACCCCGCGACGGGAA

CGCAGTAGGCACGATGTTGTA

880

iutA

Forward

Reverse

GGCTGGACATCATGGGAACTGG

CGTCGGGAACGGGTAGAATCG

300

kpsMT II

Forward

Reverse

GCGCATTTGCTGATACTGTTG

CATCCAGACGATAAGCATGAGCA

272

kpsMT III

Forward

Reverse

TCCTCTTGCTACTATTCCCCCT

AGGCGTATCCATCCCTCCTAAC

392

rfc

Forward

Reverse

ATCCATCAGGAGGGGACTGGA

AACCATACCAACCAATGCGAG

788

ibeA

Forward

Reverse

AGGCAGGTGTGCGCCGCGTAC

TGGTGCTCCGGCAAACCATGC

170

cvaC

Forward

Reverse

CACACACAAACGGGAGCTGTT

CTTCCCGCAGCATAGTTCCAT

680

traT

Forward

Reverse

GGTGTGGTGCGATGAGCACAG

CACGGTTCAGCCATCCCTGAG

290

PAI

Forward

Reverse

GGACATCCTGTTACATCGCGCA

TCGCCACCAATCACAGCCGAAC

930

  1. PAI pathogenicity island